201 related articles for article (PubMed ID: 20665497)
21. p21WAF1 expression is associated with improved survival after adjuvant chemoradiation for pancreatic cancer.
Ahrendt SA; Brown HM; Komorowski RA; Zhu YR; Wilson SD; Erickson BA; Ritch PS; Pitt HA; Demeure MJ
Surgery; 2000 Oct; 128(4):520-30. PubMed ID: 11015084
[TBL] [Abstract][Full Text] [Related]
22. The fate of pancreatic tumor cell lines following p16 overexpression depends on the modulation of CDK2 activity.
Calbó J; Serna C; Garriga J; Graña X; Mazo A
Cell Death Differ; 2004 Oct; 11(10):1055-65. PubMed ID: 15309028
[TBL] [Abstract][Full Text] [Related]
23. Low P16
Fu HC; Chuang IC; Yang YC; Chuang PC; Lin H; Ou YC; Chang Chien CC; Huang HS; Kang HY
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30150594
[TBL] [Abstract][Full Text] [Related]
24. The impact of immunohistochemical staining with ezrin-carbonic anhydrase IX and neuropilin-2 on prognosis in patients with metastatic renal cell cancer receiving tyrosine kinase inhibitors.
Cetin B; Gonul II; Buyukberber S; Afsar B; Gumusay O; Algın E; Turan N; Ozet A; Benekli M; Coskun U
Tumour Biol; 2015 Nov; 36(11):8471-8. PubMed ID: 26026587
[TBL] [Abstract][Full Text] [Related]
25. Relationship between epidermal growth factor receptor status, p16(INK4A), and outcome in head and neck squamous cell carcinoma.
Young RJ; Rischin D; Fisher R; McArthur GA; Fox SB; Peters LJ; Corry J; Lim A; Waldeck K; Solomon B
Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1230-7. PubMed ID: 21467228
[TBL] [Abstract][Full Text] [Related]
26. Clinical outcome and expression of mutant P53, P16, and Smad4 in lung adenocarcinoma: a prospective study.
Bian C; Li Z; Xu Y; Wang J; Xu L; Shen H
World J Surg Oncol; 2015 Mar; 13():128. PubMed ID: 25890228
[TBL] [Abstract][Full Text] [Related]
27. P16
Ishikawa M; Nakayama K; Nakamura K; Yamashita H; Ishibashi T; Minamoto T; Sawada K; Yoshimura Y; Iida K; Razia S; Ishikawa N; Nakayama S; Otsuki Y; Kyo S
Sci Rep; 2021 Sep; 11(1):18236. PubMed ID: 34521948
[TBL] [Abstract][Full Text] [Related]
28. Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplification.
Betof AS; Rabbani ZN; Hardee ME; Kim SJ; Broadwater G; Bentley RC; Snyder SA; Vujaskovic Z; Oosterwijk E; Harris LN; Horton JK; Dewhirst MW; Blackwell KL
Br J Cancer; 2012 Feb; 106(5):916-22. PubMed ID: 22333602
[TBL] [Abstract][Full Text] [Related]
29. p16(INK4a) is a marker of good prognosis for primary invasive penile squamous cell carcinoma: a multi-institutional study.
Gunia S; Erbersdobler A; Hakenberg OW; Koch S; May M
J Urol; 2012 Mar; 187(3):899-907. PubMed ID: 22245329
[TBL] [Abstract][Full Text] [Related]
30. High nuclear poly-(ADP-ribose)-polymerase expression is prognostic of improved survival in pancreatic cancer.
Klauschen F; von Winterfeld M; Stenzinger A; Sinn BV; Budczies J; Kamphues C; Bahra M; Wittschieber D; Weichert W; Striefler J; Riess H; Dietel M; Denkert C
Histopathology; 2012 Sep; 61(3):409-16. PubMed ID: 22384823
[TBL] [Abstract][Full Text] [Related]
31. Loss of p16(INK4a) is associated with reduced patient survival in soft tissue tumours, and indicates a senescence barrier.
Knösel T; Altendorf-Hofmann A; Lindner L; Issels R; Hermeking H; Schuebbe G; Gibis S; Siemens H; Kampmann E; Kirchner T
J Clin Pathol; 2014 Jul; 67(7):592-8. PubMed ID: 24747207
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of carbonic anhydrase IX expression by cancer-associated fibroblasts in lung adenocarcinoma.
Nakao M; Ishii G; Nagai K; Kawase A; Kenmotsu H; Kon-No H; Hishida T; Nishimura M; Yoshida J; Ochiai A
Cancer; 2009 Jun; 115(12):2732-43. PubMed ID: 19365853
[TBL] [Abstract][Full Text] [Related]
33. Different cellular p16(INK4a) localisation may signal different survival outcomes in head and neck cancer.
Zhao N; Ang MK; Yin XY; Patel MR; Fritchie K; Thorne L; Muldrew KL; Hayward MC; Sun W; Wilkerson MD; Chera BS; Hackman T; Zanation AM; Grilley-Olson JE; Couch ME; Shockley WW; Weissler MC; Shores CG; Funkhouser WK; Olshan AF; Hayes DN
Br J Cancer; 2012 Jul; 107(3):482-90. PubMed ID: 22735904
[TBL] [Abstract][Full Text] [Related]
34. Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer.
Hussain SA; Ganesan R; Reynolds G; Gross L; Stevens A; Pastorek J; Murray PG; Perunovic B; Anwar MS; Billingham L; James ND; Spooner D; Poole CJ; Rea DW; Palmer DH
Br J Cancer; 2007 Jan; 96(1):104-9. PubMed ID: 17213826
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer.
Oshima M; Okano K; Muraki S; Haba R; Maeba T; Suzuki Y; Yachida S
Ann Surg; 2013 Aug; 258(2):336-46. PubMed ID: 23470568
[TBL] [Abstract][Full Text] [Related]
36. p16INK4A in oral squamous cell carcinomas--a correlation with biological behaviors: immunohistochemical and FISH analysis.
Suzuki H; Sugimura H; Hashimoto K
J Oral Maxillofac Surg; 2006 Nov; 64(11):1617-23. PubMed ID: 17052587
[TBL] [Abstract][Full Text] [Related]
37. Tumor suppressor p16INK4a controls oncogenic K-Ras function in human pancreatic cancer cells.
Rabien A; Sanchez-Ruderisch H; Schulz P; Otto N; Wimmel A; Wiedenmann B; Detjen KM
Cancer Sci; 2012 Feb; 103(2):169-75. PubMed ID: 22049925
[TBL] [Abstract][Full Text] [Related]
38. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck.
Lassen P; Eriksen JG; Hamilton-Dutoit S; Tramm T; Alsner J; Overgaard J
J Clin Oncol; 2009 Apr; 27(12):1992-8. PubMed ID: 19289615
[TBL] [Abstract][Full Text] [Related]
39. The prognostic impact of cyclin dependent kinase inhibitors p21WAF1, p27Kip1, and p16INK4/MTS1 in adenocarcinomas of the uterine cervix: an immunohistochemical evaluation of expression patterns in population-based material from 142 patients with international federation of gynecology and obstetrics stage I and II adenocarcinoma.
Alfsen GC; Reed W; Sandstad B; Kristensen GB; Abeler VM
Cancer; 2003 Nov; 98(9):1880-9. PubMed ID: 14584070
[TBL] [Abstract][Full Text] [Related]
40. Expression of p14ARF, p15INK4b, p16INK4a, and DCR2 increases during prostate cancer progression.
Zhang Z; Rosen DG; Yao JL; Huang J; Liu J
Mod Pathol; 2006 Oct; 19(10):1339-43. PubMed ID: 16799475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]